STX: Shield to assume full US control of ACCRUFER
Shield will assume full US commercial control of ACCRUFER, aiming to enhance profitability and growth prospects, improve financial performance and expand operational capacity in the $2.3B US iron deficiency market.
Shield will assume full US commercial control of ACCRUFER®, a move the company says will enhance profitability and growth prospects. Shield said the transaction is expected to improve financial performance, expand operational capacity and strengthen ACCRUFER®'s position in the $2.3B US iron deficiency market.